-The Financial Express A forensic report prepared for the Serious Fraud Investigation Office (SFIO) shows over a third of India's top 500 companies, including those in the top 100, are "managing" their accounts. It finds that companies where promoters hold more than 50% of total shareholding are more likely to take such steps to impress markets with their performance. Both domestic companies and subsidiaries of multinationals listed in India show similar trends...

-The Hindu Business Line The Congress law and the BJP's amended version both fail to address the lack of transparency in property deals A toxic mix of hypocrisy, amnesia, opportunism, ignorance, and paternalism has led to a mess on the land acquisition legislation. It seems certain that whatever law we end up with is going to be bad law. It will not serve the primary purpose of any eminent domain law -...

-The Times of India It was in 2012 that the Centre first promised to provide free drugs in public health facilities. The first budgetary provision was made in 2013. Last year, the promise was crystallized to providing 348 essential drugs free. This was later whittled down to just 50 drugs. And now, the entire idea of a central scheme for free drug distribution has been given a quiet burial. Joint secretary (policy)...

-The Hindu The Indira Gandhi Matritva Sahyog Yojana was introduced to provide partial wage compensation during pregnancy, but various issues plague its implementation The latest official figures indicate that India is well short of meeting the Millennium Development Goals that pledged to reduce the country's maternal mortality ratio (MMR) by three quarters and the infant mortality rate (IMR) by two-thirds. The Sample Registration System (SRS), 2013, records MMR at 167 per 1,00,000...

-CurrentNews.in ‘Make in India' an empty slogan; Govt promotes ‘Sell in India'  The government of the USA is pushing India to revise its existing robust Intellectual Property (IP) framework that effectively protects the national and public interest by balancing the rights of IP owners with their obligation to society. Submitting to the US agenda will adversely impact innovation, production and prices, especially of medicines and medical care. Multinational pharmaceutical companies will reap...